Richards hadn't yet provided Seeking Alpha with additional information confirming the stock ownership, Moriarty added.
In his response to this story mentioned above, Richards doesn't answer any of the stock ownership questions raised about his fund, Williams and Wurlitzer.
Efforts to reach Williams and Wurlitzer weren't successful. Wurlitzer has been published in two medical journals, according to a search of the PubMed database. The first, in 2003, was a comment on an article about physician-detectives in 20th century literature. The second Wurlitzer piece, from 2010, commented on an article describing burnout among U.S. surgeons.
Last fall, Richards wrote several Seeking Alpha articles claiming Roche (RHHBY) was in talks to buy Aeterna for "over $4.70 per share." No such deal has been announced.In Tuesday trading, Keryx shares were dwon 16% to $4.13 while Aeterna shares were down 15% to $1.83. --Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here: Adam Feuerstein. >To follow the writer on Twitter, go to http://twitter.com/adamfeuerstein. >To submit a news tip, send an email to: email@example.com. Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV